BR112023017666A2 - Métodos para controle de infestações de pulgas e carrapatos em mamíferos - Google Patents

Métodos para controle de infestações de pulgas e carrapatos em mamíferos

Info

Publication number
BR112023017666A2
BR112023017666A2 BR112023017666A BR112023017666A BR112023017666A2 BR 112023017666 A2 BR112023017666 A2 BR 112023017666A2 BR 112023017666 A BR112023017666 A BR 112023017666A BR 112023017666 A BR112023017666 A BR 112023017666A BR 112023017666 A2 BR112023017666 A2 BR 112023017666A2
Authority
BR
Brazil
Prior art keywords
mammal
flea
active material
tick
period
Prior art date
Application number
BR112023017666A
Other languages
English (en)
Inventor
R Winkle Joseph
E Willard Kevin
S Readnour Robin
Original Assignee
In The Bowl Animal Health Inc
R Winkle Joseph
E Willard Kevin
S Readnour Robin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by In The Bowl Animal Health Inc, R Winkle Joseph, E Willard Kevin, S Readnour Robin filed Critical In The Bowl Animal Health Inc
Publication of BR112023017666A2 publication Critical patent/BR112023017666A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/76—1,3-Oxazoles; Hydrogenated 1,3-oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P17/00—Pest repellants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/02—Acaricides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/04—Insecticides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dentistry (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

métodos para controle de infestações de pulgas e carrapatos em mamíferos. a presente invenção refere-se a um material ativo que é oralmente administrado a um mamífero substancialmente diariamente, o qual eventualmente aumenta a concentração do material ativo no sangue de um mamífero para uma quantidade eficaz para controlar uma infestação por pulgas e/ou carrapatos do mamífero. a administração oral é então descontinuada por um período de tempo de pelo menos um dia, embora a concentração de material ativo no sangue do mamífero permaneça suficientemente alta para controlar a infestação por pulgas e/ou carrapatos. o período de tempo pode ser de três dias ou sete dias. após o período de tempo ter decorrido, administração de doses substancialmente diárias pode ser retomada para continuar mantendo a concentração de material ativo no sangue do mamífero em uma quantidade eficaz para controlar a infestação por pulgas e/ou carrapatos. a descontinuação da administração oral pode ocorrer várias vezes durante o curso de um mês ou mais. é também divulgado um método para estabelecimento de um regime para administração de um material ativo para controle de infestações de pulgas e/ou carrapatos em um mamífero usando uma dosagem que é reduzida da dose do rótulo por um período de tempo correspondente.
BR112023017666A 2021-03-11 2022-03-11 Métodos para controle de infestações de pulgas e carrapatos em mamíferos BR112023017666A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163159801P 2021-03-11 2021-03-11
PCT/US2022/019913 WO2022192648A1 (en) 2021-03-11 2022-03-11 Methods for controlling flea and tick infestations in a mammal

Publications (1)

Publication Number Publication Date
BR112023017666A2 true BR112023017666A2 (pt) 2023-11-14

Family

ID=83227137

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023017666A BR112023017666A2 (pt) 2021-03-11 2022-03-11 Métodos para controle de infestações de pulgas e carrapatos em mamíferos

Country Status (9)

Country Link
US (1) US20230413819A1 (pt)
EP (1) EP4304722A1 (pt)
JP (1) JP2024513690A (pt)
KR (1) KR20230161996A (pt)
CN (1) CN117500498A (pt)
AU (1) AU2022234415A1 (pt)
BR (1) BR112023017666A2 (pt)
CA (1) CA3211582A1 (pt)
WO (1) WO2022192648A1 (pt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516790A (en) * 1999-08-12 2003-03-28 Lilly Co Eli Oral treatment of companion animals with ectoparasiticidal spinosyns

Also Published As

Publication number Publication date
EP4304722A1 (en) 2024-01-17
WO2022192648A1 (en) 2022-09-15
CN117500498A (zh) 2024-02-02
JP2024513690A (ja) 2024-03-27
CA3211582A1 (en) 2022-09-15
AU2022234415A1 (en) 2023-09-21
US20230413819A1 (en) 2023-12-28
KR20230161996A (ko) 2023-11-28

Similar Documents

Publication Publication Date Title
Henter et al. Glutamatergic modulators in depression
Zanos et al. Convergent mechanisms underlying rapid antidepressant action
US20200323843A1 (en) Use of levocetirizine and montelukast in the treatment of viral infection caused by coronavirus
Kato et al. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: convergent mechanisms
US10092564B2 (en) Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
Van Hiele l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with ‘therapy-resistant’depressions
BR112020004947A2 (pt) canabidiol transdérmico sintético para o tratamento de epilepsia focal em adultos
JP2023061957A (ja) 抑うつ障害の処置
US20230141609A1 (en) Methods of Treating Amyotrophic Lateral Sclerosis and Symptoms
Zakaria et al. The potential role of melatonin on memory function: lessons from rodent studies
US20070292535A1 (en) Strontium compositions and methods of treating arthritic and or osteoporitic conditions
BR112023017666A2 (pt) Métodos para controle de infestações de pulgas e carrapatos em mamíferos
Pincus et al. Dietary method for reducing fluctuations in Parkinson's disease.
Kalia et al. Treatment of muscle cramps in patients with cirrhosis of liver: a systematic review
JP2006508118A5 (pt)
BR112020013750A8 (pt) Dispensação intranasal de olanzapina por dispositivo olfativo de precisão
Yin et al. Latent sex differences in CaMKII-nNOS signaling that underlie antidepressant-like effects of yueju-ganmaidazao decoction in the Hippocampus
Emrich et al. The action of mood-stabilizers in affective disorders: an integrative view as a challenge
Saurat et al. Arotinoid acid (Ro 13-7410): a pilot study in dermatology
Kobayashi et al. Fursultiamine, a vitamin B1 derivative, enhances chondroprotective effects of glucosamine hydrochloride and chondroitin sulfate in rabbit experimental osteoarthritis
JP2018177773A (ja) 医薬
Trigo et al. MDMA reinstates cocaine-seeking behaviour in mice
RU2746295C1 (ru) Способ обезболивания и седации в стоматологии
US10213444B2 (en) Composition and method for treating bipolar disorder
US20240041806A1 (en) Eyedrops for Inhibiting Myopia Progression in Children and Screening Method for Inhibitor of Myopia Progression in Children